ARUP and Gestalt Diagnostics announced a partnership under which ARUP will adopt Gestalt’s PathFlow® platform as a foundation for future digital pathology initiatives.
ARUP researchers contributed knowledge and insights to a variety of laboratory medicine specialty areas in 2022.
ARUP researchers coauthored more than 160 peer-reviewed articles on groundbreaking research in 2022. Their insights and innovation helped advance laboratory medicine for improved patient outcomes.
The Spring 2023 edition of Magnify: The Art and Science of Diagnostic Medicine, is now available online and explores the legacy and future of transfusion medicine at ARUP.
ARUP Associate Medical Director Steven Baker, MD, PhD, will lead research that aims to determine whether gene therapies can be developed to treat patients living with creatine transporter deficiency (CTD).
Drawing on ARUP experts' extensive knowledge about the diagnosis and treatment of cerebral creatine deficiency syndromes, a new initiative seeks answers for those with creatine transporter deficiency.
Rong Mao, MD, FACMG, has been elected to the American College of Medical Genetics and Genomics (ACMG) Foundation board of directors. Her two-year term will begin with the ACMG annual meeting on March 14, 2023.
Rong Mao, MD, FACMG, looks forward to bridging the gap between laboratory and clinical practice after her recent election to the ACMGF board of directors, and will present at the ACMG meeting.
Allison Carey, MD, PhD, pictured in her lab at the University of Utah, developed a molecular barcoding approach to identify genetic variants that make some strains of Mycobacterium avium more resistant to antibiotics.
Allison Carey, MD, PhD, ARUP medical director of Hematopathology, was one of six U faculty members recognized for research excellence and invited to share their stories at the Vitae 2022 symposium.
Jennifer (Jenna) Rychert, PhD, ARUP medical director of Operational Informatics and Microbial Immunology, and Jonathan Genzen, MD, PhD, ARUP chief medical officer, coauthored the report of the new study, “Laboratory-Developed Test Orders in an Academic Health System.”
Laboratory-developed tests made up only about 4% of an academic health system’s total test orders in 2021, yet they played an important role in patient care, a new study shows.
The Fall 2022 edition of Magnify: The Art and Science of Diagnostic Medicine, shares how ARUP has applied what it learned from COVID-19 to improve operations, services, and, ultimately, patient care.
Ryan Metcalf, MD, CQA(ASQ), section chief of Transfusion Medicine at ARUP and University of Utah Health, at ARUP Blood Services, a collection site for an ARUP/University of Utah Health study to determine whether convalescent plasma is an effective treatment for COVID-19.
Based on data from 21,916 participants in 33 studies, the Association for the Advancement of Blood and Biotherapies (AABB) has issued guidelines for use of convalescent plasma in COVID-19 treatment.
In her lab at the University of Utah, Allison Carey, MD, PhD, is using a molecular barcoding approach she developed to identify the genes that allow some strains of Mycobacterium avium to establish chronic infections and resist treatment with antibiotics.
The National Institute of Allergy and Infectious Diseases has awarded Medical Director Allison Carey, MD, PhD, $1.5 million over five years to fund her groundbreaking research.
Patricia Slev, PhD, section chief of Immunology at ARUP Laboratories, coauthored a newly published study that looked at COVID-19-related risks facing emergency department workers early in the pandemic.
A new study for which ARUP provided COVID-19 testing and expertise found that emergency department workers early in the pandemic faced the highest risk of infection from community spread.
The Summer 2022 edition of Magnify, now online, features a look at the challenges of autoimmune neurologic testing, our experts in this area, and recent awards, and catches up with a former fellow.